CIBER

New predictive method for the progression of colorectal cancer

Biomarkers
Cancer
It has been patented a new fetal 'gene signatureĺ capable to predict the worse evolution of the CRC patients who could suffer a relapse after chemotherapeutic regime or surgery.
2Preclinical Validation, 1R+D
Spain